Search

Your search keyword '"Llorca, F."' showing total 1,411 results

Search Constraints

Start Over You searched for: Author "Llorca, F." Remove constraint Author: "Llorca, F."
1,411 results on '"Llorca, F."'

Search Results

2. Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial

3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

4. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

6. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

7. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)

9. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

10. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

12. Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

14. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

15. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

16. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

17. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

18. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

19. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

22. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

27. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)

28. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

31. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

32. Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

33. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.

34. Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

39. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

40. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

43. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

44. Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

47. Medical students faced with related and unrelated living kidney donation: a stratified and multicentre study in Spain

Catalog

Books, media, physical & digital resources